Nov 17 - Britain's FTSE 100 .FTSE index is seen opening 12 points lower at
6,409 on Tuesday, according to financial bookmakers
* COVID-19: Britain has secured 5 million doses of an experimental COVID-19
vaccine developed by Moderna Inc MRNA.O after it reported positive trial
results, health minister Matt Hancock said on Monday, with the earliest doses
expected for delivery in spring. * BREXIT: European Union diplomats warned Britain on Monday that time was
fast running out for a Brexit deal, and that it may already be too late to
ratify one, as negotiators in Brussels began a last-ditch attempt to avoid a
tumultuous exit at the end of December. * GOLD: Gold prices edged higher as the dollar slipped, while investors
weighed concerns over spiking coronavirus cases globally against optimism over
positive developments around a second possible COVID-19 vaccine. * OIL: Oil prices edged higher on expectations OPEC and its allies will
extend oil production cuts for at least three months, while sentiment was
bolstered by news of another promising coronavirus vaccine. * The UK blue-chip index .FTSE closed 1.7% higher on Monday as positive
vaccine data from drugmaker Moderna bolstered hopes of a swift economic recovery
to pre-pandemic levels, offsetting concerns over a post-Brexit trade deal with
the European Union. UK CORPORATE DIARY:
Ninety One Plc N91.L HY earnings
EasyJet Plc EZJ.L FY earnings
Big Yellow Group Plc BYG.L HY earnings
Assura Plc AGRP.L HY earnings
Imperial Brands Plc IMB.L FY earnings
Aggreko Plc AGGK.L Q3 trading statement
Telecom Plus Plc TEP.L HY results
HomeServe Plc HSV.L HY earnings
Intermediate Capital Group Plc ICP.L HY earnings
Experian Plc EXPN.L HY earnings
Focusrite Plc TUNE.L FY earnings
* For more on the factors affecting European stocks, please click on:
LIVE/
TODAY'S UK PAPERS
> Financial Times PRESS/FT
> Other business headlines PRESS/GB